Ketamine Effects Timeline
Ketamine produces rapid therapeutic effects within 40 minutes to 2 hours after intravenous administration, with peak antidepressant effects typically observed at 24 hours. 1, 2
Onset of Action by Route
Intravenous Administration (Most Studied)
- Immediate anesthetic effects: The FDA label confirms that the initial alpha phase lasts approximately 45 minutes with a half-life of 10-15 minutes, corresponding clinically to the anesthetic effect 2
- Antidepressant/antisuicidal effects: Begin within 40 minutes of infusion completion 1
- Peak therapeutic benefit: Occurs at 24 hours post-infusion 1, 3
- Duration of effect: Typically lasts 1-2 weeks after a single infusion 4, 3
Intramuscular Administration
- Time to peak plasma concentration: 10-30 minutes 5
- Maximal plasma concentrations: Range from 27 ng/mL (at 0.1 mg/kg) to 1970 ng/mL (at 6.0 mg/kg) 5
Clinical Context: Depression and Suicidal Ideation
The evidence demonstrates a remarkably rapid onset compared to traditional antidepressants (which require 1-2 weeks or longer):
- At 40 minutes post-infusion: Significant reduction in suicidal ideation with large effect sizes (d = 1.05 overall; d = 2.36 in patients with high baseline suicidal ideation) 1
- At 230 minutes (approximately 4 hours): Effects persist but with diminishing effect sizes (d = 0.45) 1
- At 24 hours: Maximum antidepressant efficacy is typically reached 1, 3
- At 1 week: Effects generally persist but begin to wane 4, 3
Important Clinical Considerations
Standard dosing protocol: Most studies utilized 0.5 mg/kg IV ketamine infused over 40 minutes 1
Cardiovascular effects occur rapidly: Blood pressure elevation reaches maximum within a few minutes of injection and usually returns to baseline within 15 minutes 2
Common pitfall: The rapid onset can be misleading—while initial effects appear within 40 minutes, the full antidepressant response builds over the first 24 hours. Don't assess treatment failure too early.
Duration limitation: The therapeutic effect is transient (1-2 weeks), necessitating repeated infusions for sustained benefit 4, 3. Studies using six serial infusions over 2 weeks showed maintained reduction in symptoms during treatment 1
Route matters: The evidence base is strongest for IV administration. Oral ketamine has variable bioavailability (41.1-93.0%) and less established efficacy data 5, 6